Ligand · 0GM
0GM · N-[(5S,9S,10S,13S)-9-hydroxy-5,10-bis(2-methylpropyl)-4,7,12,16-tetraoxo-3,6,11,17-tetraazabicyclo[17.3.1]tricosa-1(23),19,21-trien-13-yl]-3-(naphthalen-1-yl)-2-(naphthalen-1-ylmethyl)propanamide
0GM, N-[(5S,9S,10S,13S)-9-hydroxy-5,10-bis(2-methylpropyl)-4,7,12,16-tetraoxo-3,6,11,17-tetraazabicyclo[17.3.1]tricosa-1(23),19,21-trien-13-yl]-3-(naphthalen-1-yl)-2-(naphthalen-1-ylmethyl)propanamide (C51 H61 N5 O6, 840.1 g/mol), in the…
- Component
- 0GM
- Formula
- C51 H61 N5 O6
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
0GM in 4 structures; the first of them:
- 1FQ5 · X-ray structure of a cyclic statine inhibitor PD-129,541 bound to yeast proteinase A · 0GM A338 · binds ALA12, GLN13, ILE30, ASP32, GLY34, SER35, ILE73, GLN74 and 18 more
- 1GVV · Five Atomic Resolution Structures of Endothiapepsin Inhibitor Complexes; implications for… · 0GM A402 · binds ASP33, ASP35, GLY37, SER38, ILE77, SER78, TYR79, GLY80 and 11 more
- 1FQ5 · X-ray structure of a cyclic statine inhibitor pd-129,541 bound to yeast proteinase a · 0GM A338 · binds ALA12, GLN13, ILE30, ASP32, GLY34, SER35, ILE73, GLN74 and 18 more
- 1GVV · Five atomic resolution structures of endothiapepsin inhibitor complexes; implications for… · 0GM A402 · binds ASP33, ASP35, GLY37, SER38, ILE77, SER78, TYR79, GLY80 and 11 more
Residues it binds most
ILE 4, GLY 4, ASP 4, PHE 4, SER 4, THR 4, TYR 4, GLN 2, LEU 2, ALA 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.